Comprehensive single-cell analysis deciphered microenvironmental dynamics and immune regulator olfactomedin 4 in pathogenesis of gallbladder cancer.
He H, Chen S, Yu Y, Fan Z, Qian Y, Dong Y, Song Y, Zhong C, Sun X, Cao Q, Li S, Huang W, Li W, Zhuang M, Yang J, Wang X, Wang J, Wu D, Wang H, Wen W., Free PMC Article

OLFM4 modulates intestinal inflammation by promoting IL-22(+)ILC3 in the gut.
Xing Z, Li X, He J, Chen Y, Zhu L, Zhang X, Huang Z, Tang J, Guo Y, He Y., Free PMC Article

Blocking OLFM4/galectin-3 axis in placental polymorphonuclear myeloid-derived suppressor cells triggers intestinal inflammation in newborns.
Lv S, Chen M, Li Z, Huang Z, Wan S, Kuang S, Peng L, Ye J, Yang M, Li J, He Y.

LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study.
Xu K, Zheng P, Zhao S, Wang J, Feng J, Ren Y, Zhong Q, Zhang H, Chen X, Chen J, Xie P., Free PMC Article

Olfactomedin 4 produces dysplasia but suppresses metastasis of colon cancer.
Ma HW, Kim JM, Kim DH, Park IS, Kim JH, Park KC, Seo DH, Kim JH, Che X, Kim TI, Cheon JH, Kim SW.

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer.
Jaitner S, Pretzsch E, Neumann J, Schäffauer A, Schiemann M, Angele M, Kumbrink J, Schwitalla S, Greten FR, Brandl L, Klauschen F, Horst D, Kirchner T, Jung A., Free PMC Article

Olfactomedin-4-Positive Neutrophils in Neonates: Link to Systemic Inflammation and Bronchopulmonary Dysplasia.
Al Gharaibeh FN, Kempton KM, Alder MN., Free PMC Article

New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease.
Bertran L, Jorba-Martin R, Barrientos-Riosalido A, Portillo-Carrasquer M, Aguilar C, Riesco D, Martínez S, Vives M, Sabench F, Castillo DD, Richart C, Auguet T., Free PMC Article

OLFM4 deficiency delays the progression of colitis to colorectal cancer by abrogating PMN-MDSCs recruitment.
Chen Z, Zhang X, Xing Z, Lv S, Huang L, Liu J, Ye S, Li X, Chen M, Zuo S, Tao Y, He Y.

Olfactomedin 4 Is Not a Precise Marker for Human Intestinal Stem Cells, But Is Involved in Intestinal Carcinogenesis.
Liu W, Rodgers GP.

Increased expression of OLFM4 and lysozyme during necrotizing enterocolitis in neonates: an observational research study.
Diez S, Renner M, Bahlinger V, Hartmann A, Besendörfer M, Müller H., Free PMC Article

Olfactomedin 4 regulates migration and proliferation of immortalized non-transformed keratinocytes through modulation of the cell cycle machinery and actin cytoskeleton remodelling.
Cárdenas-León CG, Klaas M, Mäemets-Allas K, Arak T, Eller M, Jaks V.

Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer.
Okamoto T, duVerle D, Yaginuma K, Natsume Y, Yamanaka H, Kusama D, Fukuda M, Yamamoto M, Perraudeau F, Srivastava U, Kashima Y, Suzuki A, Kuze Y, Takahashi Y, Ueno M, Sakai Y, Noda T, Tsuda K, Suzuki Y, Nagayama S, Yao R., Free PMC Article

Overexpression of Cancer-Associated Stem Cell Gene OLFM4 in the Colonic Epithelium of Patients With Primary Sclerosing Cholangitis.
Neyazi M, Bharadwaj SS, Bullers S, Varenyiova Z, Oxford IBD Cohort Study Investigators, Travis S, Arancibia-Cárcamo CV, Powrie F, Geremia A., Free PMC Article

Olfm4 Is Highly Expressed in HCC Patients and as a Biomarker and Therapeutic Target for HCC.
Wei Y, Song Q, Zhang F, Yuan T., Free PMC Article

Quantitative Proteomic Analysis of Synovial Tissue Reveals That Upregulated OLFM4 Aggravates Inflammation in Rheumatoid Arthritis.
Ren X, Geng M, Xu K, Lu C, Cheng Y, Kong L, Cai Y, Hou W, Lu Y, Aihaiti Y, Xu P.

A neutrophil subset defined by intracellular olfactomedin 4 is associated with mortality in sepsis.
Kangelaris KN, Clemens R, Fang X, Jauregui A, Liu T, Vessel K, Deiss T, Sinha P, Leligdowicz A, Liu KD, Zhuo H, Alder MN, Wong HR, Calfee CS, Lowell C, Matthay MA., Free PMC Article

Super-enhancer-associated long noncoding RNA AC005592.2 promotes tumor progression by regulating OLFM4 in colorectal cancer.
Yan L, Chen H, Tang L, Jiang P, Yan F., Free PMC Article

Olfactomedin 4 mediation of prostate stem/progenitor-like cell proliferation and differentiation via MYC.
Li H, Chaitankar V, Zhu J, Chin K, Liu W, Pirooznia M, Rodgers GP., Free PMC Article

Clinicopathological significance of olfactomedin-4 in extrahepatic bile duct carcinoma.
Jun SY, An S, Huh T, Chung JY, Hong SM.

Olfactomedin 4-Positive Neutrophils Are Upregulated after Hemorrhagic Shock.
Kassam AF, Levinsky NC, Mallela JP, Angel K, Opoka A, Lahni P, Sahay RD, Fei L, Nomellini V, Wong HR, Alder MN., Free PMC Article

Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma.
Ye L, Kriegl L, Reiter FP, Munker SM, Itzel T, Teufel A, Ziesch A, Török HP, Kirchner T, Gerbes AL, Guba M, Mayerle J, De Toni EN., Free PMC Article

OLFM4 Expression in Ductal Carcinoma In Situ and in Invasive Breast Cancer Cohorts by a SWATH-Based Proteomic Approach.
Valo I, Raro P, Boissard A, Maarouf A, Jézéquel P, Verriele V, Campone M, Coqueret O, Guette C.

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer.
Ohkuma R, Yada E, Ishikawa S, Komura D, Ishizaki H, Tamada K, Kubota Y, Hamada K, Ishida H, Hirasawa Y, Ariizumi H, Satoh E, Shida M, Watanabe M, Onoue R, Ando K, Tsurutani J, Yoshimura K, Yokobori T, Sasada T, Aoki T, Murakami M, Norose T, Ohike N, Takimoto M, Izumizaki M, Kobayashi S, Tsunoda T, Wada S., Free PMC Article

OLFM4 Inhibits Epithelial-Mesenchymal Transition and Metastatic Potential of Cervical Cancer Cells.
Li J, Liu C, Li D, Wan M, Zhang H, Zheng X, Jie X, Zhang P, Li J, Hou H, Sun Q., Free PMC Article